Fmr LLC Harrow Health, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Fmr LLC holds 3,498 shares of HROW stock, worth $139,465. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,498

Previous 4,959 29.46%

Holding current value

$139,465

Previous $131,000 19.08%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$22.2 - $31.61 $32,434 - $46,182	-1,461 Reduced 29.46%	3,498 $106,000
Q1 2025 May 12, 2025	SELL	$22.22 - $36.67 $155,939 - $257,350	-7,018 Reduced 58.6%	4,959 $131,000
Q4 2024 Feb 13, 2025	BUY	$33.39 - $57.5 $31,486 - $54,222	943 Added 8.55%	11,977 $401,000
Q3 2024 Nov 13, 2024	BUY	$20.85 - $46.47 $193,050 - $430,265	9,259 Added 521.63%	11,034 $496,000
Q2 2024 Aug 13, 2024	BUY	$10.0 - $21.64 $12,460 - $26,963	1,246 Added 235.54%	1,775 $37,000
Q1 2024 May 13, 2024	BUY	$9.3 - $13.23 $3,189 - $4,537	343 Added 184.41%	529 $6,000
Q4 2023 Feb 13, 2024	SELL	$8.1 - $16.36 $135,845 - $274,373	-16,771 Reduced 98.9%	186 $2,000
Q3 2023 Nov 13, 2023	BUY	$14.03 - $22.08 $233,010 - $366,704	16,608 Added 4758.74%	16,957 $243,000
Q2 2023 Aug 11, 2023	BUY	$17.37 - $28.08 $4,203 - $6,795	242 Added 226.17%	349 $6,000
Q2 2022 Aug 12, 2022	SELL	$5.75 - $7.74 $3.64 Million - $4.89 Million	-632,203 Reduced 99.98%	107 $1,000
Q1 2022 May 13, 2022	SELL	$6.77 - $8.66 $1.55 Million - $1.99 Million	-229,315 Reduced 26.61%	632,310 $4.31 Million
Q4 2021 Feb 14, 2022	BUY	$8.5 - $12.0 $1.69 Million - $2.39 Million	199,238 Added 30.08%	861,625 $7.44 Million
Q3 2021 Nov 15, 2021	BUY	$6.99 - $10.6 $4.63 Million - $7.02 Million	662,387 New	662,387 $6.02 Million

Others Institutions Holding HROW

# of Institutions

175

Shares Held

21.5M

Call Options Held

390K

Put Options Held

413K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.08B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account